iCarbonX Completes Series A Financing, Tencent As Strategic Lead Investor, Valuation Close to $1 Billion

iCarbonX has finished its Series A financing round, raising over $100 million, with an approximate $1 billion post-money valuation. Major investors of the A round financing include internet industry giant Tencent, a leader in the stem cell industry, Zhongyuan Union, and Tianfu Group, which has a strong capital position. In addition to the capital support for the future development of iCarbonX, the strategic investment will also set a solid foundation of strategic cooperation among companies in the life health industry, internet industry and many other related industries.


iCarbonX will now devote itself to four professional fields: precision skincare, precision nutrition, precision health and precision medicine. Based on the extensive collection, accumulation and integration of data, iCarbonX will build an ecosystem of big data in these four areas.

 

iCarbonX has already developed a framework in order to reach its goals, including the following five platforms:

-Data collecting and technical platform, to produce and collect data throughout a person’s entire life;

-Data analysis platform of artificial intelligence;

-Intelligent hardware, focused on collecting data and serving as an extension interface for products and services;

-Database and sample library, for storing data and samples;

-A platform for providing customized service to every customer.



iCarbonX is committed to building a customer-centric platform of healthcare data and an artificial intelligence engine, based on mobile internet and internet of things, integrating related leading resources around the globe, so as to provide all-round, personalized life health management programs and related applications to every end user, and to significantly improve the products and services of related industries.

 

 

About iCarbonX


Founded in October 2015, iCarbonX aims to build an ecosystem of digital life based on a combination of an individual’s biological, behavioral and psychological data, the Internet and artificial intelligence. The management team has deep experience in omics technology, mobile health, medical service, biological data analysis, artificial intelligence and data mining. Based on a growing digital life network, together with the world's leading partners, we plan to interpret and study your digital life to provide personalized products and services for a healthier and better life. For more information, please visit: www.icarbonx.com